Literature DB >> 16754414

Clinical and demographic factors associated with DSM-IV melancholic depression.

Ahsan Y Khan1, Joe Carrithers, Sheldon H Preskorn, Rex Lear, Stephen R Wisniewski, A John Rush, Diane Stegman, Colleen Kelley, Karen Kreiner, Andrew A Nierenberg, Maurizio Fava.   

Abstract

BACKGROUND: The purpose of this paper is to use demographic and clinical data from a large diverse group of outpatients diagnosed with non-psychotic major depression to investigate the validity of the DSM-IV concept of melancholic depression.
METHODS: Baseline clinical and demographic data were collected on 1500 outpatients (1456 of whom melancholia could be determined) with non-psychotic major depressive disorder (MDD) participating in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Depressive symptom severity was assessed by clinical telephone interview using the 17-item Hamilton Rating Scale for Depression (HRS-D17) and the 30-item Inventory of Depressive Symptomatology (IDS-C30). The types and degrees of concurrent psychiatric symptoms were measured using a self report, the Psychiatric Diagnostic Screening Questionnaire (PDSQ), by recording the number of items relevant to each diagnostic category endorsed by study participants.
RESULTS: Adjusting for severity of depression (as measured by the total HRS-D17 scores), no differences were found in the rate of melancholic depression by race, marital status, education, employment status, family history of depression, primary care versus specialty care, monthly income, and degree of psychiatric and medical co-morbidity. Melancholic depression was significantly more likely in men than women. Melancholic depression after adjustment for severity was associated with a slightly younger age at study entry, as well as with greater illness severity, and slightly shorter duration of current episode. Hispanic ethnicity was associated with lower melancholic depression rates at the .06 level of significance.
CONCLUSIONS: Among outpatients with MDD, melancholic features were less likely in Hispanic patients, but more likely in slightly younger patients and in men. Melancholic features were also related to a slightly shorter current episode. These findings are consistent with the notion that external socio-demographic factors do not play an important role in the pathophysiology of melancholic depression.

Entities:  

Mesh:

Year:  2006        PMID: 16754414     DOI: 10.1080/10401230600614496

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  25 in total

1.  THE RELATIONSHIPS AMONG VIGILANT COPING STYLE, RACE, AND DEPRESSION.

Authors:  Thomas A LaVeist; Roland J Thorpe; Geraldine Pierre; GiShawn A Mance; David R Williams
Journal:  J Soc Issues       Date:  2014-06-01

2.  Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Authors:  Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-14       Impact factor: 4.035

3.  Depressive Symptoms, Substance Use and Partner Violence Victimization Associated with HIV Disclosure Among Men Who have Sex with Men.

Authors:  Monique J Brown; Julianne M Serovich; Judy A Kimberly
Journal:  AIDS Behav       Date:  2016-01

4.  Cardiovascular disease in persons with depressive and anxiety disorders.

Authors:  Nicole Vogelzangs; Adrie Seldenrijk; Aartjan T F Beekman; Hein P J van Hout; Peter de Jonge; Brenda W J H Penninx
Journal:  J Affect Disord       Date:  2010-03-12       Impact factor: 4.839

5.  Person misfit on the Inventory of Depressive Symptomatology: Low quality self-report or true atypical symptom profile?

Authors:  Judith M Conijn; Philip Spinhoven; Rob R Meijer; Femke Lamers
Journal:  Int J Methods Psychiatr Res       Date:  2016-11-14       Impact factor: 4.035

6.  Do depressed patients with diabetes experience more side effects when treated with CitalopramThan their counterparts without diabetes? a STAR*D study.

Authors:  Charlene Bryan; Thomas Songer; Maria Mori Brooks; Michael E Thase; Bradley Gaynes; Michael Klinkman; G K Balasubramani; A John Rush; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

7.  The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.

Authors:  Charlotte L Haley; Sharon C Sung; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; James F Luther; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2013-03       Impact factor: 2.681

Review 8.  [Core symptoms of depression. Effectiveness of antidepressant therapy].

Authors:  J Damm; D Eser; C Schüle; H-J Möller; R Rupprecht; T C Baghai
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

9.  What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Authors:  Diane Warden; A John Rush; Stephen R Wisniewski; Ira M Lesser; Susan G Kornstein; G K Balasubramani; Michael E Thase; Sheldon H Preskorn; Andrew A Nierenberg; Elizabeth A Young; Kathy Shores-Wilson; Madhukar H Trivedi
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

10.  Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

Authors:  Susan G Kornstein; Marisa Toups; A John Rush; Stephen R Wisniewski; Michael E Thase; James Luther; Diane Warden; Maurizio Fava; Madhukar H Trivedi
Journal:  J Womens Health (Larchmt)       Date:  2013-02       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.